


Candesartan 98%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-02-15
Product Details
- Product NameCandesartan
- CAS No.139481-59-7
- EINECS No.604-138-8
- MFC24H20N6O3
- MW440.45
- AppearancesolidWhite
- Melting point 183-185°C
- storage temp. Inert atmosphere,Store in freezer, under -20°C
- Water Solubility Soluble in ethyl acetate, methanol, water (<1 mg/ml at 25°C), DMSO (88 mg/ml at 25°C), and ethanol (1 mg/ml at 25°C).
- Boiling point 754.8±70.0 °C(Predicted)
- density 1.41±0.1 g/cm3(Predicted)
Company Profile Introduction
LAVYBENS pharma is one of the leading pharma companies of the Country.
Lavybens pharma is a totally vertically integrated service and product manufacturer for pharmaceutical companies.company offering the pharmaceutical commercial manufacturing bulk intermediates/development of active pharmaceutical ingredients/contract manufacturing/CRO/and manufacturer and supplier of pharmaceutical impurity reference standards global presence in over countries.
Lavybens pharma's competitive advanced manufacturing facilities, R&D capabilities, extensive domestic network in indian pharma market and international.
Recommended supplier
-
VIP2年
- Molsyns Research
- 139481-59-7 98%
- Inquiry
- 2024-04-01
-
VIP1年
- Sibram Pharmaceutical
- Candesartan 139481-59-7 99%
- Inquiry
- 2024-03-16
-
VIP1年
- Vijaya Pharma And Life Science
- Candesartan 98%
- Inquiry
- 2024-03-13
-
VIP1年
- Vishrudh laboratories pvt ltd
- Candesartan 139481-59-7 98%
- Inquiry
- 2024-03-01
- Since:2021-02-01
- Address: 401, 4th Floor, Sri Lakshmi Nilayam Complex, Saleem Nagar, Malakpet, Hyderabad, Telangana-500036, In
INQUIRY